Increasingly, policy makers and payers are focusing on value, defined as the health outcome achieved per dollar spent, to increase the return on health care expenditures. In a series of studies, KNG Health researchers, working with several partners and clients, have examined the societal and economic value of treatment for musculoskeletal conditions. These conditions include: end-stage osteoarthritis of the knee, hip fracture, disc herniation, rotator cuff tears, anterior cruciate ligament tears, and sacroiliac joint dysfunction. Using regression and Markov modeling techniques, the KNG Health Team has developed a Musculoskeletal Care Value Model® (MSK-VM®) that associates MSK conditions with functional limitations and clinical and non-clinical outcomes (e.g., ability to work). Across all the KNG Health studies, the findings demonstrate that treatment for the selected conditions is cost effective and the importance of considering the benefits to society, in terms of increased earnings, avoided nursing home costs, and other indirect-cost factors, when assessing the full benefit of medical treatment. A full list of the publications appears below, as well as a supplement to a recent paper published in the Journal of ClinicoEconomics and Outcomes Research.
- Modeling the indirect economic implications of musculoskeletal disorders and treatment
- The Direct and Indirect Costs to Society of Treatment for End-Stage Knee Osteoarthritis